Left ventricular and left atrial thrombi in sinus rhythm patients with dilated ischemic cardiomyopathy

Aurora Bakalli1, Ljubica Georgievska-Ismail, Dardan Koçinaj

  • 1Department of Cardiology, Clinic of Internal Medicine, University Clinical Center of Kosova, Prishtine, Kosovo. abakalli@hotmail.com

Insights

In patients with ischemic cardiomyopathy, left atrial appendage thrombi are common, occurring in 40.3%. Larger left ventricular size and lack of aspirin therapy predict left ventricular thrombi.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Thrombosis Research

Background:

  • Ischemic dilated cardiomyopathy creates conditions favorable for left ventricular (LV) thrombus formation.
  • The left atrial appendage (LAA) can also be a source of thrombi in patients with heart disease.

Purpose of the Study:

  • To determine the prevalence of LV and LAA thrombi in patients with chronic ischemic dilated cardiomyopathy in sinus rhythm.
  • To identify echocardiographic predictors of thrombus formation in these patients.

Main Methods:

  • The study included 57 patients with chronic dilated ischemic cardiomyopathy in sinus rhythm, excluding those on anticoagulation or with specific comorbidities.
  • Transthoracic echocardiography and transesophageal echocardiography were performed for all participants.

Main Results:

  • Left ventricular (LV) thrombus was found in 19.3% of patients, and left atrial appendage (LAA) thrombus in 40.3%.
  • Independent predictors for LV thrombus included larger LV size (p=0.05) and lack of aspirin therapy (p=0.02).
  • Lower LV ejection fraction (EF) (p=0.02) and larger LAA maximal area (p=0.004) predicted LAA thrombus.

Conclusions:

  • This study highlights the significant possibility of LAA thrombi in addition to LV thrombi in patients with chronic ischemic cardiomyopathy and sinus rhythm.
  • LV size, LV EF, LAA maximal area, and aspirin use are independent predictors of left heart chamber thrombi in this population.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...